Alex Zwiers

Alex has over 20 years of experience in pharmaceutical industry, mainly regulatory affairs, and responsible for over 100 registration files. His scientific and regulatory interests have enabled him to build up a large network in the pharmaceutical industry, the regulatory framework and scientific world. He was involved in the development of Sugammadex from the early research phase to marketing authorisation approvals in Europe and several other countries. He was also led the teams responsible for the interaction strategy and management of impurities of Sugammadex. Alex is also the founder and CEO of Zwiers Regulatory Consultancy, providing pharma companies with quality regulatory support, throughout the entire drug lifecycle. His company has been responsible for bringing several products to the market which have an impact on coagulation or coagulation diseases (hemophilia).